Met Life Investment Management, LLC Nevro Corp Transaction History

Met Life Investment Management, LLC

$17.1 Billion
Q3 2024

A detailed history of Met Life Investment Management, LLC transactions in Nevro Corp stock. As of the latest transaction made, Met Life Investment Management, LLC holds 13,385 shares of NVRO stock, worth $60,500. This represents 0.0% of its overall portfolio holdings.

Number of Shares

13,385

Previous 20,761 35.53%

Holding current value

$60,500

Previous $174,000 57.47%

% of portfolio

0.0%

Previous 0.0%

42 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$4.71 - $10.1 $34,740 - $74,497	-7,376 Reduced 35.53%	13,385 $74,000
Q2 2024 Aug 13, 2024	BUY	$7.96 - $13.59 $14,495 - $24,747	1,821 Added 9.61%	20,761 $174,000
Q1 2024 May 14, 2024	BUY	$13.56 - $20.78 $256,826 - $393,573	18,940 New	18,940 $273,000
Q2 2023 Apr 29, 2024	BUY	$22.62 - $39.32 $428,422 - $744,720	18,940 New	18,940 $481,000
Q1 2023 May 09, 2024	BUY	$30.17 - $41.11 $571,419 - $778,623	18,940 New	18,940 $685 Million
Q1 2022 May 10, 2024	BUY	$59.95 - $92.06 $1.14 Million - $1.74 Million	18,940 New	18,940 $1.37 Million
Q1 2022 Mar 22, 2023	BUY	$59.95 - $92.06 $409,938 - $629,506	6,838 Added 56.5%	18,940 $1.37 Million
Q1 2022 May 12, 2022	BUY	$59.95 - $92.06 $409,938 - $629,506	6,838 Added 56.5%	18,940 $1.37 Million
Q4 2021 Jun 21, 2023	SELL	$81.07 - $121.29 $554,356 - $829,381	-6,838 Reduced 36.1%	12,102 $981,000
Q3 2021 Jun 21, 2023	SELL	$101.99 - $166.36 $697,407 - $1.14 Million	-6,838 Reduced 36.1%	12,102 $1.41 Million
Q2 2021 May 17, 2024	SELL	$141.6 - $179.06 $94,588 - $119,612	-668 Reduced 5.23%	12,102 $2.01 Million
Q2 2021 Jun 21, 2023	SELL	$141.6 - $179.06 $968,260 - $1.22 Million	-6,838 Reduced 36.1%	12,102 $2.01 Million
Q2 2021 Mar 22, 2023	SELL	$141.6 - $179.06 $94,588 - $119,612	-668 Reduced 5.23%	12,102 $2.01 Million
Q2 2021 Aug 16, 2021	SELL	$141.6 - $179.06 $94,588 - $119,612	-668 Reduced 5.23%	12,102 $2.01 Million
Q1 2021 May 17, 2024	SELL	$132.81 - $182.18 $819,437 - $1.12 Million	-6,170 Reduced 32.58%	12,770 $1.78 Million
Q1 2021 Jun 26, 2023	SELL	$132.81 - $182.18 $819,437 - $1.12 Million	-6,170 Reduced 32.58%	12,770 $1.78 Billion
Q1 2021 Mar 22, 2023	SELL	$132.81 - $182.18 $91,506 - $125,522	-689 Reduced 5.12%	12,770 $1.78 Million
Q1 2021 May 14, 2021	SELL	$132.81 - $182.18 $91,506 - $125,522	-689 Reduced 5.12%	12,770 $1.78 Million
Q4 2020 May 24, 2024	SELL	$138.17 - $184.34 $84,007 - $112,078	-608 Reduced 4.32%	13,459 $2.33 Million
Q4 2020 Jun 22, 2023	SELL	$138.17 - $184.34 $757,309 - $1.01 Million	-5,481 Reduced 28.94%	13,459 $2.33 Million
Q4 2020 Mar 22, 2023	SELL	$138.17 - $184.34 $84,007 - $112,078	-608 Reduced 4.32%	13,459 $2.33 Million
Q4 2020 Feb 16, 2021	SELL	$138.17 - $184.34 $84,007 - $112,078	-608 Reduced 4.32%	13,459 $2.33 Million
Q3 2020 May 24, 2024	SELL	$114.09 - $145.51 $82,258 - $104,912	-721 Reduced 4.88%	14,067 $1.96 Billion
Q3 2020 Jun 26, 2023	SELL	$114.09 - $145.51 $555,960 - $709,070	-4,873 Reduced 25.73%	14,067 $1.96 Million
Q3 2020 Mar 22, 2023	SELL	$114.09 - $145.51 $82,258 - $104,912	-721 Reduced 4.88%	14,067 $1.96 Million
Q3 2020 Nov 13, 2020	SELL	$114.09 - $145.51 $82,258 - $104,912	-721 Reduced 4.88%	14,067 $1.96 Million
Q2 2020 May 24, 2024	SELL	$89.45 - $129.85 $371,396 - $539,137	-4,152 Reduced 21.92%	14,788 $1.77 Billion
Q2 2020 Jun 26, 2023	SELL	$89.45 - $129.85 $371,396 - $539,137	-4,152 Reduced 21.92%	14,788 $1.77 Million
Q2 2020 Mar 22, 2023	BUY	$89.45 - $129.85 $157,253 - $228,276	1,758 Added 13.49%	14,788 $1.77 Million
Q2 2020 Aug 14, 2020	BUY	$89.45 - $129.85 $157,253 - $228,276	1,758 Added 13.49%	14,788 $1.77 Million
Q1 2020 Jul 12, 2023	SELL	$70.23 - $144.31 $415,059 - $852,872	-5,910 Reduced 31.2%	13,030 $1.3 Million
Q4 2019 Jul 12, 2023	SELL	$76.41 - $117.54 $451,583 - $694,661	-5,910 Reduced 31.2%	13,030 $1.53 Million
Q3 2019 Jul 12, 2023	SELL	$61.52 - $91.1 $363,583 - $538,401	-5,910 Reduced 31.2%	13,030 $1.12 Million
Q2 2019 Jul 12, 2023	SELL	$58.04 - $66.99 $343,016 - $395,910	-5,910 Reduced 31.2%	13,030 $844,000
Q1 2019 Jul 13, 2023	SELL	$35.52 - $62.62 $209,923 - $370,084	-5,910 Reduced 31.2%	13,030 $814,000
Q4 2018 Jul 13, 2023	SELL	$35.43 - $56.29 $209,391 - $332,673	-5,910 Reduced 31.2%	13,030 $506,000
Q4 2018 Mar 22, 2023	SELL	$35.43 - $56.29 $255,450 - $405,850	-7,210 Reduced 35.62%	13,030 $506,000
Q4 2018 Feb 14, 2019	SELL	$35.43 - $56.29 $255,450 - $405,850	-7,210 Reduced 35.62%	13,030 $507,000
Q3 2018 Jul 13, 2023	SELL	$44.22 - $75.47 $261,340 - $446,027	-5,910 Reduced 31.2%	13,030 $742,000
Q3 2018 Mar 22, 2023	BUY	$44.22 - $75.47 $57,486 - $98,111	1,300 Added 6.86%	20,240 $1.15 Million
Q3 2018 Nov 14, 2018	BUY	$44.22 - $75.47 $318,826 - $544,138	7,210 Added 55.33%	20,240 $1.15 Million
Q4 2017 Feb 15, 2018	BUY	$65.94 - $93.31 $859,198 - $1.22 Million	13,030	13,030 $900,000

Others Institutions Holding NVRO

# of Institutions

151

Shares Held

39.3M

Call Options Held

67.9K

Put Options Held

1.59M

View Full List

About NEVRO CORP

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $160M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

More about NVRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Account

Met Life Investment Management, LLC Nevro Corp Transaction History